Arca
Skip to content

NextCure, Inc.

3 private offerings reported to the SEC on Form D since 2016, $129.9M sold in all. Biotech, MD.

  • Form D offerings: 3
  • Reported sold: $129.9M
  • Newest: Dec 10, 2025

Every Form D Offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
Dec 10, 2025$21.5M$21.5MNextCure, Inc.Biotech · MDNot amended0001104659-25-119801
Nov 19, 2018$93.4M$93.4MNextCure, Inc.Biotech · MDNot amended0001567619-18-006604
Jan 11, 2016$15.0M$67.0MNextCure, Inc.Biotech · MDNot amended0001140361-16-047469

SEC Profile

From the company's EDGAR record
Ticker
NXTC
Business address
Baltimore, Md
Incorporated in
DE
SEC industry
Pharmaceutical Preparations
All SEC filings
CIK 1661059 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.